Čeština | Dansk | Deutsch | English | Español | Français | Italiano | Nederlands | Norsk | Polski | Português | Pусский | Suomi | Svenska | US
Euro Huntington's disease network [logo]
EHDN2016 ENFERMEDAD GRUPO REGISTRY PROYECTOS ENTRAR
 
 
  
Grupos de trabajo- Nuevos métodos de evaluación - Fenotipo Motor -
--->Novedades
[-]El proyecto
--->Sponsor
--->[+]Comité Ejecutivo
--->[+]Writing Committee Strategic ...
--->[+]Comité Científico y Bioético
--->Coordinador central
--->Coordinadores locales
--->Fellowship Programme
--->[+]Constitución
--->[+]Elecciones
--->[+]Miembros
[-]Centros
--->[+]Austria
--->[-]Bélgica
--->Coordinador
--->Asociaciones de Huntingto...
--->Antwerpen
--->[+]Bierbeek
--->Bruselas - VUB
--->Bruselas - UCL
--->Bruxelles - ULB
--->Charleroi
--->Leuven
--->Liège (Luik)
--->[+]República Checa
--->[+]Dinamarca
--->[+]Finlandia
--->[+]Francia
--->[-]Alemania
--->Coordinador
--->Asociaciones de EH
--->Standard of Care
--->Aachen
--->Berlin
--->Bochum
--->Bonn
--->Dresden
--->Dinslaken
--->Düsseldorf
--->Erlangen
--->Freiburg
--->Hamburg
--->Hannover
--->HH-Heiligenhafen
--->Itzehoe
--->Marburg
--->[+]Lübeck
--->Marburg-KPP
--->Mainz
--->München
--->München-LMU
--->Münster
--->Rostock
--->Taufkirchen
--->Ulm
--->[+]Würzburg
--->[+]Ireland
--->[+]Italia
--->[+]Países Bajos
--->[+]Noruega
--->[+]Polonia
--->[+]Portugal
--->[+]Rusia
--->[+]España
--->[+]Suecia
--->[+]Suiza
--->[+]Reino Unido
--->[+]Fuera de Europa
[-]Grupos de trabajo
--->[+]EH avanzada
--->[+]Fenotipo conductual
--->[+]Modificadores Biológicos
--->[+]Biomarcadores
--->[+]Banco de tejidos y cerebros...
--->[+]Fenotipo cognitivo
--->[+]Modificadores ambientales
--->[+]Evaluación Funcional
--->[+]Test y Consejo genético
--->[+]Genes Modificadores
--->[+]Economia de Salud
--->[+]Pruebas de imagen
--->[+]Huntington Juvenil
--->[-]Fenotipo motor
--->[+]Acontecimientos
--->[+]Reuniones
--->[+]Tratamiento Neuroprotector...
--->[+]Fisioterapia
--->[+]Calidad de vida
--->[+]Cuidados del paciente
--->[+]Tratamiento quirúrgico
--->[+]Tratamiento Sintomático
--->[+]Jóvenes
[-]Eventos
--->[+]EHDN 2016
--->EHDN 2014
--->Announcement
--->Introduction
--->Registration
--->Programme Fri
--->Programme Sat
--->Programme Sun
--->Additional Meetings
--->CME points
--->Sponsoring
--->Travel Information
--->Hotel Booking
--->Reimbursement
--->Social Activities
--->[+]Abstract Submission
--->Contacts
--->Feedback
--->[+]EHDN 2012
--->[+]EHDN 2010
--->[+]EHDN 2008
--->[-]EHDN 2007
--->Programa
--->Reuniones
--->Bienvenido
--->[+]Sobre Dresden
--->[+]EHDN 2006
--->[-]EHDN 2005
--->Programa
--->Cena oficial
--->Inscripción
--->Grupos de Trabajo
--->Localización
--->Manchester
--->Valoración y Feedback
--->[+]EHDN 2004
[+]Comunicación
--->Ofertas de trabajo

Agenda

This working group will address the following issues:
  1. UHDRS-TMS teaching video: To guide and to improve the clinical assessments as performed by motor raters in EHDN, the working group will compile a teaching video for the UHDRS total motor score (TMS). The video will offer a "UHDRS-Library" illustrating the different scores defined in the UHDRS-TMS by clinical examples. It will also provide an instructional section teaching how to perform the UHDRS examination and how to rate the different subitems (this project is funded by High-Q-Foundation and started in August 2006).  
  2. Revised-UHDRS-TMS: To improve the sensitivity of the UHDRS-TMS to assess disease progression, a factorial analysis of the TMS subitems based on data from REGISTRY and other databases will be performed to identify redundant items and ‘difficult to score’ items (=  items displaying high variability). A revised version of the UHDRS-TMS will be tested prospectively in EHDN, e.g. in REGISTRY (this project is funded by High-Q-Foundation and started in August 2006).   
  3. Motor-Biomarkers: To develop, explore and prospectively test novel quantitative motor assessment tools that may be used as objective outcome measures in clinical trials in HD in the setting of multicenter clinical trials, e.g. REGISTRY. This project will be conducted in close cooperation with other workgroups (application for funding in preparation).
  4. PT and OT in HD: To explore the role and benefit of different approaches of physiotherapy and occupational therapy in clinical trials in HD applying evidence based prospective study designs. The motor workgroup recognizes the need to provide evidence for the efficacy of PT and OT in HD, since limited budgets in healthcare systems will challenge the availability of such resources (application for funding in preparation). 
(edited by Ralf Reilmann, Mar. 17, 2008 - )

Líder

Raymund A.C. Roos, Prof. MD
Neurologist, Comité Ejecutivo, Evaluador motor, Delegado del grupo Motor, Investigador principal
Leiden University Medical Centre (LUMC), Neurology K5-Q
Dirección postal: P.O. Box 9600
2300 RC Leiden
Nederland
Teléfono: +31 71 5262197
Fax: +31 71 5248253
Correo electrónico: 
Prof. Dr. med. Jean-Marc Burgunder
Neurologist, Chair of Comité Ejecutivo, Investigador principal, Delegado del grupo Motor
Universitätsspital Bern, Neurologie
Dirección postal: Worbstrasse 312
3073 Bern-Gümligen
Schweiz
Teléfono: +41 (0)31 352 20 70
Fax: +41 (0)31 351 80 70
Correo electrónico: 
Dr. med. Ralf Reilmann
Direktor, Delegado del grupo Motor, Delegado del grupo Neuroprotective Therapy, Investigador principal
George-Huntington-Institut, Neurologie
Dirección postal: Technologiepark Münster / Johann-Krane-Weg 27
48149 Münster
Deutschland
Teléfono: +49 251 788-788-0
Fax: +49 251 788-788-88
Correo electrónico: 
página web: www.george-huntington-institut.de

Associated Language Area Coordinator (Lanco)

Lisanne Mütze, Germany

Links
about us | privacy statement | disclaimer | terms of use